Catch up on today’s top five analyst initiations with this list compiled by The Fly: 1. BioXcel Therapeutics (BTAI) initiated with a Buy at Goldman Sachs. 2. 1Life Healthcare (ONEM) initiated with an Outperform at Credit Suisse. 3. Durect (DRRX) initiated with a Buy at Chardan. 4. 9 Meters Biopharma (NMTR) initiated with a Buy at Maxim. 5. Aldeyra (ALDX) initiated with a Buy at Jefferies. This list is just a portion of The Fly’s analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post